Bartosz Piech
Research Subjects
Bartosz Piech has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Alicja Judzińska
University Clinical Hospital No. 1 in Lublin, Lublin, Poland
10 shared publications - Emilia Trojanowska
SP ZOZ MSWiA in Lublin, Lublin, Poland
10 shared publications - Julia Osipowska
University Clinical Hospital No. 1 in Lublin, Lublin, Poland
10 shared publications - Justyna Ignarska
University Clinical Hospital No. 4 in Lublin, Doktora Kazimierza Jaczewskiego 8, 20-954 Lublin, Poland
10 shared publications - Kamila Sobczyńska
Stefan Cardinal Wyszyński Provincial Specialist Hospital in Lublin, Lublin, Poland
10 shared publications - Magda Terbosh
University Clinical Hospital No. 1 in Lublin, Lublin, Poland
10 shared publications
Latest Publications
- Open Access
- 26 June 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 3 (2(50))
BUERGER’S DISEASE - A GENERAL OVERVIEW WITH A FOCUS ON NEW THERAPEUTIC APPROACHES
Introduction: Buerger's disease (thromboangiitis obliterans, TAO) is an inflammatory disease affecting small and medium-sized blood vessels, primarily in the extremities. This condition leads to their gradual narrowing and occlusion, resulting in impaired blood flow and tissue ischemia. It most often affects young adults, particularly men. It is strongly associated with tobacco use, which is considered a key risk factor for disease development and progression. Clinical presentation includes limb pain, intermittent claudication, ulceration, and, in advanced cases, tissue necrosis. Although treatment is primarily centered on smoking cessation and symptom relief, recent advances in therapeutic approaches show promising potential. Purpose: The aim of this review is to discuss Buerger's disease in the context of its pathogenesis, diagnosis, and clinical presentation, and to analyze current therapeutic options. Methodology: A narrative literature review was conducted in PubMed to identify studies on thromboangiitis obliterans. The search strategy included the keywords "Buerger’s disease" (accounting for variant - "Buerger disease"), "thromboangiitis obliterans" and "treatment". Additionally, reference lists of selected articles were screened to identify further relevant publications. Studies published between 2000 and 2025 and directly related to the topic were included. Conclusions: Advances in the understanding and management of Buerger’s disease have led to the development of new therapeutic approaches. However, current evidence remains limited, and further well-designed studies are needed to establish optimal treatment strategies and improve patient outcomes.
- 26 June 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 3 (2(50))
Open AccessBUERGER’S DISEASE - A GENERAL OVERVIEW WITH A FOCUS ON NEW THERAPEUTIC APPROACHES
Introduction: Buerger's disease (thromboangiitis obliterans, TAO) is an inflammatory disease affecting small and medium-sized blood vessels, primarily in the extremities. This condition leads to their gradual narrowing and occlusion, resulting in impaired blood flow and tissue ischemia. It most often affects young adults, particularly men. It is strongly associated with tobacco use, which is considered a key risk factor for disease development and progression. Clinical presentation includes limb pain, intermittent claudication, ulceration, and, in advanced cases, tissue necrosis. Although treatment is primarily centered on smoking cessation and symptom relief, recent advances in therapeutic approaches show promising potential. Purpose: The aim of this review is to discuss Buerger's disease in the context of its pathogenesis, diagnosis, and clinical presentation, and to analyze current therapeutic options. Methodology: A narrative literature review was conducted in PubMed to identify studies on thromboangiitis obliterans. The search strategy included the keywords "Buerger’s disease" (accounting for variant - "Buerger disease"), "thromboangiitis obliterans" and "treatment". Additionally, reference lists of selected articles were screened to identify further relevant publications. Studies published between 2000 and 2025 and directly related to the topic were included. Conclusions: Advances in the understanding and management of Buerger’s disease have led to the development of new therapeutic approaches. However, current evidence remains limited, and further well-designed studies are needed to establish optimal treatment strategies and improve patient outcomes.
- Open Access
- 26 June 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 3 (2(50))
TIRZEPATIDE AND METABOLIC TREATMENT OF OBSTRUCTIVE SLEEP APNEA IN OBESE PATIENTS - EMERGING THERAPEUTIC PERSPECTIVES
Obstructive sleep apnea (OSA) is a highly prevalent and underdiagnosed sleep-related breathing disorder characterized by recurrent upper airway obstruction during sleep, leading to intermittent hypoxia and sleep fragmentation. Its incidence continues to rise in parallel with the global obesity epidemic, which represents the most significant modifiable risk factor for OSA. While continuous positive airway pressure remains the gold standard of symptomatic treatment, long-term adherence is often suboptimal, highlighting the need for alternative, disease-modifying therapeutic strategies. This paper explores the role of incretin-based therapies, particularly glucagon-like peptide-1 receptor agonists, focusing mainly on tirzepatide, in the management of OSA. Current evidence suggests that these medications contribute to significant weight reduction, improvement in metabolic parameters, and potential attenuation of OSA severity, as reflected by reductions in the apnea–hypopnea index and hypoxic burden. Beyond weight loss, emerging data indicate that incretin-based therapies may influence key pathophysiological mechanisms of OSA, including systemic inflammation, oxidative stress, and ventilatory control instability. These pleiotropic effects may be particularly relevant in non-obese patients, in whom non-anatomical factors play a predominant role. For these reasons, tirzepatide represents a promising therapeutic approach in the management of OSA.
- 26 June 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 3 (2(50))
Open AccessTIRZEPATIDE AND METABOLIC TREATMENT OF OBSTRUCTIVE SLEEP APNEA IN OBESE PATIENTS - EMERGING THERAPEUTIC PERSPECTIVES
Obstructive sleep apnea (OSA) is a highly prevalent and underdiagnosed sleep-related breathing disorder characterized by recurrent upper airway obstruction during sleep, leading to intermittent hypoxia and sleep fragmentation. Its incidence continues to rise in parallel with the global obesity epidemic, which represents the most significant modifiable risk factor for OSA. While continuous positive airway pressure remains the gold standard of symptomatic treatment, long-term adherence is often suboptimal, highlighting the need for alternative, disease-modifying therapeutic strategies. This paper explores the role of incretin-based therapies, particularly glucagon-like peptide-1 receptor agonists, focusing mainly on tirzepatide, in the management of OSA. Current evidence suggests that these medications contribute to significant weight reduction, improvement in metabolic parameters, and potential attenuation of OSA severity, as reflected by reductions in the apnea–hypopnea index and hypoxic burden. Beyond weight loss, emerging data indicate that incretin-based therapies may influence key pathophysiological mechanisms of OSA, including systemic inflammation, oxidative stress, and ventilatory control instability. These pleiotropic effects may be particularly relevant in non-obese patients, in whom non-anatomical factors play a predominant role. For these reasons, tirzepatide represents a promising therapeutic approach in the management of OSA.
- Open Access
- 26 June 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 3 (2(50))
CONTINUOUS GLUCOSE MONITORING IN DIABETES MANAGEMENT: CLINICAL BENEFITS AND THE ROLE OF FREESTYLE LIBRE
Diabetes poses a significant public health challenge and requires effective methods for monitoring and managing glucose levels. Traditional approaches, such as glycated hemoglobin (HbA1c) and self-monitoring of blood glucose (SMBG), have important limitations, including a limited ability to assess glycemic variability and detect hypoglycemic episodes. This study aims to present the development of continuous glucose monitoring (CGM) technologies, evaluate their impact on metabolic control and patients’ quality of life, and analyze the role of the FreeStyle Libre system in modern diabetes care. This literature review is based on an analysis of randomized controlled trials, observational studies, and clinical guidelines regarding CGM use. Real-world data and recent evidence on the development of diabetes technologies were also included. The findings indicate that CGM use is associated with improved glycemic control, including reduced HbA1c levels, increased time in range (TIR), and fewer hypoglycemic episodes. The FreeStyle Libre system, as an example of flash glucose monitoring technology, is particularly effective in reducing hypoglycemia, while real-world data suggest additional improvements in HbA1c levels. In summary, CGM represents a key component of modern diabetes care, enabling a more precise and personalized approach to treatment and supporting the digital transformation of healthcare.
- 26 June 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 3 (2(50))
Open AccessCONTINUOUS GLUCOSE MONITORING IN DIABETES MANAGEMENT: CLINICAL BENEFITS AND THE ROLE OF FREESTYLE LIBRE
Diabetes poses a significant public health challenge and requires effective methods for monitoring and managing glucose levels. Traditional approaches, such as glycated hemoglobin (HbA1c) and self-monitoring of blood glucose (SMBG), have important limitations, including a limited ability to assess glycemic variability and detect hypoglycemic episodes. This study aims to present the development of continuous glucose monitoring (CGM) technologies, evaluate their impact on metabolic control and patients’ quality of life, and analyze the role of the FreeStyle Libre system in modern diabetes care. This literature review is based on an analysis of randomized controlled trials, observational studies, and clinical guidelines regarding CGM use. Real-world data and recent evidence on the development of diabetes technologies were also included. The findings indicate that CGM use is associated with improved glycemic control, including reduced HbA1c levels, increased time in range (TIR), and fewer hypoglycemic episodes. The FreeStyle Libre system, as an example of flash glucose monitoring technology, is particularly effective in reducing hypoglycemia, while real-world data suggest additional improvements in HbA1c levels. In summary, CGM represents a key component of modern diabetes care, enabling a more precise and personalized approach to treatment and supporting the digital transformation of healthcare.
- Open Access
- 25 June 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 3 (2(50))
SOCIAL MEDIA USE AND ANXIETY IN ADOLESCENTS: MECHANISMS, CONTEXT, AND DIGITAL INTERVENTIONS — A NARRATIVE REVIEW
The widespread use of social media among adolescents has drawn increasing attention to its potential impact on mental health, particularly anxiety. However, existing findings are heterogeneous and sometimes difficult to interpret due to differences in study design and measurement approaches. The aim of this narrative review was to synthesize current evidence on the relationship between social media use and anxiety in adolescents, with a focus on patterns of use, underlying mechanisms, contextual factors, and digital interventions. A literature search was conducted across major peer-reviewed databases, including PubMed, ScienceDirect, and other relevant sources. Studies were included if they examined social media use in relation to anxiety or related mental health outcomes in adolescent populations. Both empirical studies and review articles were considered. Overall, available evidence suggests that social media use is associated with anxiety symptoms, although the strength of this relationship is generally modest and varies across studies. The impact of social media appears to depend less on time spent online and more on patterns of engagement and individual vulnerability. Multiple mechanisms, including social comparison, fear of missing out, sleep disruption, and exposure to negative online experiences, have been proposed to help explain these associations. The relationship also appears to be bidirectional, with adolescents experiencing anxiety potentially engaging differently with social media. Digital interventions, particularly internet-delivered cognitive behavioral therapy, show promise in reducing anxiety symptoms, although their effectiveness varies depending on user engagement and level of guidance. Current evidence suggests that social media is neither inherently harmful nor universally beneficial, and its impact appears to depend on how, why, and in what context it is used. Further research using longitudinal designs and improved measurement approaches is needed to better understand these relationships.
- 25 June 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 3 (2(50))
Open AccessSOCIAL MEDIA USE AND ANXIETY IN ADOLESCENTS: MECHANISMS, CONTEXT, AND DIGITAL INTERVENTIONS — A NARRATIVE REVIEW
The widespread use of social media among adolescents has drawn increasing attention to its potential impact on mental health, particularly anxiety. However, existing findings are heterogeneous and sometimes difficult to interpret due to differences in study design and measurement approaches. The aim of this narrative review was to synthesize current evidence on the relationship between social media use and anxiety in adolescents, with a focus on patterns of use, underlying mechanisms, contextual factors, and digital interventions. A literature search was conducted across major peer-reviewed databases, including PubMed, ScienceDirect, and other relevant sources. Studies were included if they examined social media use in relation to anxiety or related mental health outcomes in adolescent populations. Both empirical studies and review articles were considered. Overall, available evidence suggests that social media use is associated with anxiety symptoms, although the strength of this relationship is generally modest and varies across studies. The impact of social media appears to depend less on time spent online and more on patterns of engagement and individual vulnerability. Multiple mechanisms, including social comparison, fear of missing out, sleep disruption, and exposure to negative online experiences, have been proposed to help explain these associations. The relationship also appears to be bidirectional, with adolescents experiencing anxiety potentially engaging differently with social media. Digital interventions, particularly internet-delivered cognitive behavioral therapy, show promise in reducing anxiety symptoms, although their effectiveness varies depending on user engagement and level of guidance. Current evidence suggests that social media is neither inherently harmful nor universally beneficial, and its impact appears to depend on how, why, and in what context it is used. Further research using longitudinal designs and improved measurement approaches is needed to better understand these relationships.
- Open Access
- 23 June 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 3 (2(50))
MANAGEMENT OF INSOMNIA IN AGING POPULATIONS: COMPARING THE INFLUENCE OF BENZODIAZEPINES AND Z-DRUGS ON COGNITIVE HEALTH AND NEURODEGENERATIVE RISK - A REVIEW OF THE LITERATURE
Background: Insomnia is a prevalent sleep disorder among older adults and is associated with impaired cognitive function and increased risk of neurodegenerative diseases. Pharmacological management commonly involves benzodiazepines and non-benzodiazepine “Z-drugs” (zolpidem, zaleplon, zopiclone), which act as sedative-hypnotics through modulation of GABAA receptors. Although cognitive-behavioral therapy is the first-line treatment, hypnotic medications remain widely prescribed. Aim: This review evaluates the mechanisms linking benzodiazepines and Z-drugs to neurodegeneration and summarizes the clinical and epidemiological evidence regarding their long-term impact on cognitive function in older adults. Methods: A literature review was conducted using PubMed, PMC, and Google Scholar databases, focusing on full-text, English-language publications from 2013–2025. Search terms included “benzodiazepines and dementia risk,” “Z-drugs and cognitive impairment,” and drug-specific names such as zolpidem, zopiclone, zaleplon, and diazepam. Both observational and mechanistic studies were considered. Results: Long-term benzodiazepine use is consistently associated with an increased risk of cognitive decline and dementia, particularly with higher cumulative doses and long-acting compounds. Evidence for Z-drugs suggests a generally more favorable cognitive profile at low doses or short-term use, although high-dose or long-term exposure may similarly increase dementia risk and adverse events such as falls and fractures. The underlying mechanisms involve modulation of GABAergic neurotransmission, potentially altering hippocampal and cortical network activity, synaptic plasticity and memory consolidation. The interpretation of causality is complicated by potential confounding factors, such as underlying insomnia or anxiety. Conclusion: Benzodiazepines and Z-drugs are effective for insomnia management in older adults but may carry long-term cognitive risks. Minimizing dose, limiting treatment duration, and prioritizing non-pharmacological interventions such as cognitive-behavioral therapy are essential strategies to mitigate potential neurodegenerative outcomes. Future studies should aim to optimize dose–response regimens, incorporate long-term follow-up assessments, clarify the biological mechanisms through which these drugs affect cognitive function and include randomized controlled trials as well as long-term observational studies to more precisely evaluate the effects on specific cognitive domains, such as memory, attention and executive function.
- 23 June 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 3 (2(50))
Open AccessMANAGEMENT OF INSOMNIA IN AGING POPULATIONS: COMPARING THE INFLUENCE OF BENZODIAZEPINES AND Z-DRUGS ON COGNITIVE HEALTH AND NEURODEGENERATIVE RISK - A REVIEW OF THE LITERATURE
Background: Insomnia is a prevalent sleep disorder among older adults and is associated with impaired cognitive function and increased risk of neurodegenerative diseases. Pharmacological management commonly involves benzodiazepines and non-benzodiazepine “Z-drugs” (zolpidem, zaleplon, zopiclone), which act as sedative-hypnotics through modulation of GABAA receptors. Although cognitive-behavioral therapy is the first-line treatment, hypnotic medications remain widely prescribed. Aim: This review evaluates the mechanisms linking benzodiazepines and Z-drugs to neurodegeneration and summarizes the clinical and epidemiological evidence regarding their long-term impact on cognitive function in older adults. Methods: A literature review was conducted using PubMed, PMC, and Google Scholar databases, focusing on full-text, English-language publications from 2013–2025. Search terms included “benzodiazepines and dementia risk,” “Z-drugs and cognitive impairment,” and drug-specific names such as zolpidem, zopiclone, zaleplon, and diazepam. Both observational and mechanistic studies were considered. Results: Long-term benzodiazepine use is consistently associated with an increased risk of cognitive decline and dementia, particularly with higher cumulative doses and long-acting compounds. Evidence for Z-drugs suggests a generally more favorable cognitive profile at low doses or short-term use, although high-dose or long-term exposure may similarly increase dementia risk and adverse events such as falls and fractures. The underlying mechanisms involve modulation of GABAergic neurotransmission, potentially altering hippocampal and cortical network activity, synaptic plasticity and memory consolidation. The interpretation of causality is complicated by potential confounding factors, such as underlying insomnia or anxiety. Conclusion: Benzodiazepines and Z-drugs are effective for insomnia management in older adults but may carry long-term cognitive risks. Minimizing dose, limiting treatment duration, and prioritizing non-pharmacological interventions such as cognitive-behavioral therapy are essential strategies to mitigate potential neurodegenerative outcomes. Future studies should aim to optimize dose–response regimens, incorporate long-term follow-up assessments, clarify the biological mechanisms through which these drugs affect cognitive function and include randomized controlled trials as well as long-term observational studies to more precisely evaluate the effects on specific cognitive domains, such as memory, attention and executive function.
- Open Access
- 22 June 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 3 (2(50))
ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS – SOCIAL AND ETHICAL IMPLICATIONS
Artificial intelligence (AI) has become one of the most transformative technologies in contemporary medicine, particularly in the field of medical diagnostics. Advanced machine learning and deep learning systems are increasingly used to analyze medical images, clinical records and complex biomedical data, offering improvements in diagnostic accuracy, efficiency and standardization of care. Alongside these technological advancements, the integration of AI into diagnostic practice generates significant social and ethical challenges that require careful examination. The objective of this review article is to critically analyze the social and ethical implications of artificial intelligence in medical diagnostics based on existing scientific literature. This article was applied, drawing on statements of some organisations, systematic reviews, policy reports and ethical analyses published between 2018 and 2026. The findings indicate that AI-driven diagnostics can enhance early disease detection. Also it can improve access to healthcare. However, they also raise concerns regarding professional accountability, algorithmic bias, transparency, data privacy, patient autonomy and healthcare equity. The review highlights the necessity of interdisciplinary governance frameworks, ethical oversight and continuous evaluation to ensure that AI technologies are implemented in a manner consistent with the core values of medicine and social justice.
- 22 June 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 3 (2(50))
Open AccessARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS – SOCIAL AND ETHICAL IMPLICATIONS
Artificial intelligence (AI) has become one of the most transformative technologies in contemporary medicine, particularly in the field of medical diagnostics. Advanced machine learning and deep learning systems are increasingly used to analyze medical images, clinical records and complex biomedical data, offering improvements in diagnostic accuracy, efficiency and standardization of care. Alongside these technological advancements, the integration of AI into diagnostic practice generates significant social and ethical challenges that require careful examination. The objective of this review article is to critically analyze the social and ethical implications of artificial intelligence in medical diagnostics based on existing scientific literature. This article was applied, drawing on statements of some organisations, systematic reviews, policy reports and ethical analyses published between 2018 and 2026. The findings indicate that AI-driven diagnostics can enhance early disease detection. Also it can improve access to healthcare. However, they also raise concerns regarding professional accountability, algorithmic bias, transparency, data privacy, patient autonomy and healthcare equity. The review highlights the necessity of interdisciplinary governance frameworks, ethical oversight and continuous evaluation to ensure that AI technologies are implemented in a manner consistent with the core values of medicine and social justice.
- Open Access
- 22 June 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 3 (2(50))
ATHLETIC PUBALGIA – A DIAGNOSTIC AND THERAPEUTIC CHALLENGE IN CLINICAL PRACTICE
Introduction: Athletic pubalgia is a complex medical issue that affects athletes like footballers or hockey players. Chronic groin pain is caused by overuse injuries of the musculotendinous structures around the pubic symphysis. This review article aims to present the current knowledge on athletic pubalgia, including pathophysiology, epidemiology, diagnostic approaches and treatment strategies. Methods: This article is based on 30 scientific publications from PubMed, Journal of Education, Health and Sport and Google Scholar. In this review we pay attention to the latest information about risk factors, diagnostic methods, significant symptoms and management strategies. Results: Athletic pubalgia usually affects male professional athletes like football and hockey players. Groin pain coexisting with specific exercises and movements is the most common symptom. To make a correct diagnosis, the clinical picture, imaging studies, and clinical tests must be considered. First-line treatment is conservative therapy, which is sufficient in most cases. Further treatment includes special rehabilitation programs combined with surgical treatment, most often using endoscopic methods. Conclusions: Athletic pubalgia is a condition that has long been known to clinicians in the professional and recreational sport population. However, it requires detailed diagnostics, including specially selected tests performed during a physical examination and imaging techniques—particularly MRI—performed by experienced specialists. Available treatment methods, tailored to the severity of the condition, allow the vast majority of patients to fully return to sport.
- 22 June 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 3 (2(50))
Open AccessATHLETIC PUBALGIA – A DIAGNOSTIC AND THERAPEUTIC CHALLENGE IN CLINICAL PRACTICE
Introduction: Athletic pubalgia is a complex medical issue that affects athletes like footballers or hockey players. Chronic groin pain is caused by overuse injuries of the musculotendinous structures around the pubic symphysis. This review article aims to present the current knowledge on athletic pubalgia, including pathophysiology, epidemiology, diagnostic approaches and treatment strategies. Methods: This article is based on 30 scientific publications from PubMed, Journal of Education, Health and Sport and Google Scholar. In this review we pay attention to the latest information about risk factors, diagnostic methods, significant symptoms and management strategies. Results: Athletic pubalgia usually affects male professional athletes like football and hockey players. Groin pain coexisting with specific exercises and movements is the most common symptom. To make a correct diagnosis, the clinical picture, imaging studies, and clinical tests must be considered. First-line treatment is conservative therapy, which is sufficient in most cases. Further treatment includes special rehabilitation programs combined with surgical treatment, most often using endoscopic methods. Conclusions: Athletic pubalgia is a condition that has long been known to clinicians in the professional and recreational sport population. However, it requires detailed diagnostics, including specially selected tests performed during a physical examination and imaging techniques—particularly MRI—performed by experienced specialists. Available treatment methods, tailored to the severity of the condition, allow the vast majority of patients to fully return to sport.
- Open Access
- 18 June 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 3 (2(50))
VITAMIN D SUPPLEMENTATION IN BREASTFEEDING WOMEN AND VITAMIN D STATUS IN INFANTS – A REVIEW OF CURRENT CLINICAL STUDIES
Background: Vitamin D deficiency is a major public health concern, particularly among breastfed infants, whose vitamin D status depends largely on maternal 25-hydroxyvitamin D [25(OH)D] levels during pregnancy and lactation. Maternal supplementation has been proposed as a strategy to improve infant vitamin D status. Objective: This review aimed to evaluate the effect of vitamin D supplementation in breastfeeding women on 25(OH)D concentrations in exclusively breastfed infants. Materials and Methods: A narrative review of randomized controlled trials published between 2015 and 2025 was conducted. Ten studies assessing maternal vitamin D supplementation and its impact on infant 25(OH)D levels were included. Results: Maternal supplementation increased 25(OH)D levels in both mothers and infants. However, standard doses (400–800 IU/day) were often insufficient to achieve adequate vitamin D status in infants. Higher doses, particularly ≥4000 IU/day, resulted in significant improvements and, in some cases, achieved levels comparable to direct infant supplementation. Conclusions: Vitamin D supplementation in breastfeeding women may effectively improve infant vitamin D status, especially at higher doses. However, its efficacy depends on dosage, and further research is needed to determine optimal and safe supplementation strategies.
- 18 June 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 3 (2(50))
Open AccessVITAMIN D SUPPLEMENTATION IN BREASTFEEDING WOMEN AND VITAMIN D STATUS IN INFANTS – A REVIEW OF CURRENT CLINICAL STUDIES
Background: Vitamin D deficiency is a major public health concern, particularly among breastfed infants, whose vitamin D status depends largely on maternal 25-hydroxyvitamin D [25(OH)D] levels during pregnancy and lactation. Maternal supplementation has been proposed as a strategy to improve infant vitamin D status. Objective: This review aimed to evaluate the effect of vitamin D supplementation in breastfeeding women on 25(OH)D concentrations in exclusively breastfed infants. Materials and Methods: A narrative review of randomized controlled trials published between 2015 and 2025 was conducted. Ten studies assessing maternal vitamin D supplementation and its impact on infant 25(OH)D levels were included. Results: Maternal supplementation increased 25(OH)D levels in both mothers and infants. However, standard doses (400–800 IU/day) were often insufficient to achieve adequate vitamin D status in infants. Higher doses, particularly ≥4000 IU/day, resulted in significant improvements and, in some cases, achieved levels comparable to direct infant supplementation. Conclusions: Vitamin D supplementation in breastfeeding women may effectively improve infant vitamin D status, especially at higher doses. However, its efficacy depends on dosage, and further research is needed to determine optimal and safe supplementation strategies.
- Open Access
- 26 May 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 2 (2(50))
SAUNA BATHING AND CARDIOVASCULAR HEALTH: PHYSIOLOGICAL MECHANISMS, CLINICAL BENEFITS, AND PREVENTIVE IMPLICATIONS – A LITERATURE REVIEW
Introduction: Sauna bathing has evolved from a traditional cultural practice into a scientifically recognized lifestyle intervention with potential cardiovascular benefits. This literature review critically evaluates current evidence regarding the physiological mechanisms, clinical outcomes, and preventive implications of sauna use for cardiovascular health. Methods: A comprehensive search of PubMed, Scopus, Web of Science, and Google Scholar was conducted to identify studies published between 2007 and 2026, including observational cohorts, randomized controlled trials, and systematic reviews. Results: Findings show that short-term effect of Finnish sauna session on cardiovascular health include increased heart rate, enhanced cardiac output and peripheral vasodilation, mimicking physiological adaptations observed during moderate-intensity exercise. Long-term and repeated sauna use is associated with reductions in arterial stiffness, improved endothelial function, decreased systolic blood pressure, and lower risks of cardiovascular morbidity and mortality. These benefits are mediated through enhanced nitric oxide bioavailability, heat shock protein induction, anti-inflammatory effects, and improved autonomic regulation. Combining sauna bathing with other healthy behaviors, such as exercise, adequate sleep, hydration, and balanced nutrition, amplifies cardiovascular benefits. Data summary of the studies support use of the long-term sauna association with reduced arterial stiffness, improved endothelial function, lower blood pressure, lower risk of cardiovascular morbidity and mortality. These effects thought to be mediated by multiple biological mechanisms, including increased nitric oxide bioavailability, modulation of heat shock proteins, reduction of systemic inflammation, and improved autonomic balance. Conclusions: Sauna bathing is a promising, low-cost, and culturally adaptable adjunct to lifestyle-based cardiovascular prevention strategies. It should be integrated into holistic health programs, with attention to safety and individualized recommendations. Future research should establish standardized protocols, clarify dose-response relationships, and explore long-term clinical and public health impacts.
- 26 May 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 2 (2(50))
Open AccessSAUNA BATHING AND CARDIOVASCULAR HEALTH: PHYSIOLOGICAL MECHANISMS, CLINICAL BENEFITS, AND PREVENTIVE IMPLICATIONS – A LITERATURE REVIEW
Introduction: Sauna bathing has evolved from a traditional cultural practice into a scientifically recognized lifestyle intervention with potential cardiovascular benefits. This literature review critically evaluates current evidence regarding the physiological mechanisms, clinical outcomes, and preventive implications of sauna use for cardiovascular health. Methods: A comprehensive search of PubMed, Scopus, Web of Science, and Google Scholar was conducted to identify studies published between 2007 and 2026, including observational cohorts, randomized controlled trials, and systematic reviews. Results: Findings show that short-term effect of Finnish sauna session on cardiovascular health include increased heart rate, enhanced cardiac output and peripheral vasodilation, mimicking physiological adaptations observed during moderate-intensity exercise. Long-term and repeated sauna use is associated with reductions in arterial stiffness, improved endothelial function, decreased systolic blood pressure, and lower risks of cardiovascular morbidity and mortality. These benefits are mediated through enhanced nitric oxide bioavailability, heat shock protein induction, anti-inflammatory effects, and improved autonomic regulation. Combining sauna bathing with other healthy behaviors, such as exercise, adequate sleep, hydration, and balanced nutrition, amplifies cardiovascular benefits. Data summary of the studies support use of the long-term sauna association with reduced arterial stiffness, improved endothelial function, lower blood pressure, lower risk of cardiovascular morbidity and mortality. These effects thought to be mediated by multiple biological mechanisms, including increased nitric oxide bioavailability, modulation of heat shock proteins, reduction of systemic inflammation, and improved autonomic balance. Conclusions: Sauna bathing is a promising, low-cost, and culturally adaptable adjunct to lifestyle-based cardiovascular prevention strategies. It should be integrated into holistic health programs, with attention to safety and individualized recommendations. Future research should establish standardized protocols, clarify dose-response relationships, and explore long-term clinical and public health impacts.
- Open Access
- 26 May 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 2 (2(50))
THE PSYCHEDELIC AND KETAMINE RENAISSANCE IN THE FACE OF THE CRISIS IN MODERN PSYCHIATRY
Introduction: Contemporary psychiatry is grappling with a profound stagnation in innovation. It is primarily relying on the chronic management of symptoms through traditional daily-dose pharmacotherapy. The emergence of psychedelics and ketamine marks a significant departure from this model. It is offering rapid-acting, interventional alternatives that target the underlying neurobiological mechanisms of mental disorders rather than mere symptom suppression. Purpose: The primary objective of this article is to evaluate the therapeutic potential of psychedelics and ketamine as catalysts for a new paradigm in mental healthcare. The paper aims to synthesize current knowledge on 5-HT2A receptor agonism, the development of next-generation non-hallucinogenic psychoplastogens, and the ethical-legal challenges associated with implementing these treatments in the global and Polish healthcare systems. Methodology: This study employs a multidisciplinary literature review, integrating recent findings from neuropsychopharmacology, clinical trial outcomes, and bioethical analysis. It compares the efficacy and administration models of classic psychedelics against conventional treatments (e.g., SSRIs) and examines the socioeconomic factors influencing the democratization of these therapies. Conclusions: The "psychedelic renaissance" necessitates the adoption of a new language for psychiatry, rooted in neuroplasticity and connectivity. To achieve widespread scalability, the field must focus on isolating the plasticity effect and utilizing short-acting tryptamines to reduce clinical resource burdens. Furthermore, for Poland to actively participate in this medical revolution, urgent legislative harmonization and robust ethical frameworks regarding patient suggestibility are required.
- 26 May 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 2 (2(50))
Open AccessTHE PSYCHEDELIC AND KETAMINE RENAISSANCE IN THE FACE OF THE CRISIS IN MODERN PSYCHIATRY
Introduction: Contemporary psychiatry is grappling with a profound stagnation in innovation. It is primarily relying on the chronic management of symptoms through traditional daily-dose pharmacotherapy. The emergence of psychedelics and ketamine marks a significant departure from this model. It is offering rapid-acting, interventional alternatives that target the underlying neurobiological mechanisms of mental disorders rather than mere symptom suppression. Purpose: The primary objective of this article is to evaluate the therapeutic potential of psychedelics and ketamine as catalysts for a new paradigm in mental healthcare. The paper aims to synthesize current knowledge on 5-HT2A receptor agonism, the development of next-generation non-hallucinogenic psychoplastogens, and the ethical-legal challenges associated with implementing these treatments in the global and Polish healthcare systems. Methodology: This study employs a multidisciplinary literature review, integrating recent findings from neuropsychopharmacology, clinical trial outcomes, and bioethical analysis. It compares the efficacy and administration models of classic psychedelics against conventional treatments (e.g., SSRIs) and examines the socioeconomic factors influencing the democratization of these therapies. Conclusions: The "psychedelic renaissance" necessitates the adoption of a new language for psychiatry, rooted in neuroplasticity and connectivity. To achieve widespread scalability, the field must focus on isolating the plasticity effect and utilizing short-acting tryptamines to reduce clinical resource burdens. Furthermore, for Poland to actively participate in this medical revolution, urgent legislative harmonization and robust ethical frameworks regarding patient suggestibility are required.